MENU
PRTG
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Portage Biotech (PRTG) Ownership - Who owns Portage Biotech?
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs... Show more
Profile
Industry
N/A
Address
Clarence Thomas Building
Phone
+1 203 221-7378
Employees
7
Web
https://www.portagebiotech.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
11.49M
P/E Ratio
0.17
Total Cash
1.76M
Projected Growth
N/A
Total Debt
28K
Revenue
N/A
Risk (Beta)
1.43
Dividend Yield
N/A
Total Cash/Share
1.07
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
PRTG
Capitalization
11.5M
P/E Ratio
0.17
Risk (Beta)
1.43
Dividend Yield
N/A
Total Cash
1.76M
Total Cash/Share
1.07
Total Debt
28K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
1.4M
P/B Ratio
8.22
Cash Flow
N/A
Earnings
-68.17
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
220M
Current Ratio
3.08
Current Revenue Per Employee
99321.60
Dividends Per Share - Security
N/A
EBITDA
-79.36M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-141.48
Shares Held By Institutions
239K
Shares Outstanding - Current
1.65M
Total Liabilities
2.01M
Total Volume MTD
N/A
Value
-1
Gain YTD
35.010
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
Clarence Thomas Building
Phone
+1 203 221-7378
Employees
7
Web
https://www.portagebiotech.com